TARGETING FGFR2-FUSIONS WITH ANTIBODY THERAPEUTICS IN INTRAHEPATIC CHOLANGIOCARCINOMA

被引：0
|
作者：
Chaturantabut, Saireudee [1 ,2 ,3 ,4 ]
Oliver, Sydney [1 ]
Federick, Dennie T. [1 ]
Kim, John [1 ]
Robinson, Foxy [1 ]
Sellers, William R. [1 ,2 ,4 ]
机构：
[1] Broad Inst MIT & Harvard, Cambridge, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Silpakorn Univ, Fac Pharm, Bangkok, Thailand
[4] Harvard Med Sch, Boston, MA USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4713-C
引用
收藏
页码：S2139 / S2139
页数：1
相关论文
共 50 条
  • [1] Combination therapies for targeting FGFR2 fusions in cholangiocarcinoma
    Saborowski, Anna
    Vogel, Arndt
    Segatto, Oreste
    TRENDS IN CANCER, 2022, 8 (02) : 83 - 86
  • [2] FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma
    Cao, Zi
    Yang, Yichen
    Liu, Shasha
    Sun, Lin
    Liu, Yanxue
    Luo, Ye
    Wang, Jian
    Sun, Yan
    JOURNAL OF GASTROENTEROLOGY, 2025, 60 (02) : 235 - 246
  • [3] Clinical outcomes and genomic evolution of FGFR2 fusions/rearrangements in intrahepatic cholangiocarcinoma
    Cham, Brent B.
    Lee, Sunyoung S.
    CANCER RESEARCH, 2022, 82 (12)
  • [4] FGFR2 fusions and its effect of patient (pt) outcomes in intrahepatic cholangiocarcinoma (iCCA)
    Almquist, D. R.
    Javle, M.
    Ciombor, K. K.
    Roth, M.
    Abdel-Wahab, R.
    Ou, F-S.
    Wolfe, E.
    Mody, K.
    Mahipal, A.
    Borad, M. J.
    Bekaii-Saab, T.
    Ahn, D.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications
    Borad, M.
    Javle, M.
    Shaib, W. L.
    Mody, K.
    Bergamo, F.
    Harris, W. P.
    Damjanov, N.
    Macarulla, T.
    Brandi, G.
    Masi, G.
    Busset, M. Droz Dit
    Boncompagni, A.
    Dimova-Dobreva, M.
    Engelhardt, M.
    Saulay, M.
    Halfdanarson, T. R.
    Knox, J.
    Abou-Alfa, G. K.
    Personeni, N.
    Mazzaferro, V.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S567 - S568
  • [6] Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
    Tsujie, Masanori
    Iwai, Tomohisa
    Kubo, Shoji
    Ura, Takashi
    Hatano, Etsuro
    Sakai, Daisuke
    Takeda, Yutaka
    Kaibori, Masaki
    Kobayashi, Tomoe
    Katanuma, Akio
    Katayose, Yu
    Fukase, Koji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (06) : 911 - 917
  • [7] Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing.
    Farooq, Maria
    Markus, Havell
    McDonald, Bradon
    Egan, Jan B.
    Contente-Cuomo, Tania
    Odenheimer, Ahuva
    Fernandez-Zapico, Martin
    Borad, Mitesh J.
    Murtaza, Muhammed
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma
    Cleary, James M.
    Raghavan, Srivatsan
    Li, Yvonne Y.
    Spurr, Liam
    Wu, Qibiao
    Shi, Lei
    Brais, Lauren K.
    Odhiambo, Zunelly
    Goyal, Lipika
    Patel, Anuj K.
    Shinagare, Atul B.
    Clancy, Thomas E.
    Shapiro, Geoffrey
    Cerami, Ethan
    Sellers, William R.
    Hahn, William C.
    Cherniack, Andrew D.
    Bardeesy, Nabeel
    Meyerson, Matthew
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [9] FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
    Stein, Leah
    Murugesan, Karthikeyan
    Reeser, Julie W.
    Risch, Zachary
    Wing, Michele R.
    Paruchuri, Anoosha
    Samorodnitsky, Eric
    Hoskins, Emily L.
    Dao, Thuy
    Smith, Amy
    Le, Dat
    Babcook, Melissa A.
    Chang, Yi Seok
    Avenarius, Matthew R.
    Imam, Muhammad
    Freud, Aharon G.
    Roychowdhury, Sameek
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [10] Futibatinib for intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements: Japanese sub-analysis of FOENIXCCA2
    Morizane, Chigusa
    Komatsu, Yoshito
    Masuda, Kunihiro
    Kanai, Masashi
    Ioka, Tatsuya
    Ueno, Makoto
    Ozaka, Masato
    Mizuno, Takashi
    Sakai, Daisuke
    Nakamura, Masafumi
    Shimura, Masashi
    Lipika, Goyal
    Furuse, Junji
    ANNALS OF ONCOLOGY, 2023, 34 : S1380 - S1380
12345